BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 30741728)

  • 1. Animal models of post-traumatic stress disorder and novel treatment targets.
    Aspesi D; Pinna G
    Behav Pharmacol; 2019 Apr; 30(2 and 3-Spec Issue):130-150. PubMed ID: 30741728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal models of liability to post-traumatic stress disorder: going beyond fear memory.
    Cabib S; Orsini C; Puglisi Allegra S
    Behav Pharmacol; 2019 Apr; 30(2 and 3-Spec Issue):122-129. PubMed ID: 30724805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Social isolation as a promising animal model of PTSD comorbid suicide: neurosteroids and cannabinoids as possible treatment options.
    Locci A; Pinna G
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():243-259. PubMed ID: 30586627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of vagus nerve stimulation on extinction of conditioned fear and post-traumatic stress disorder symptoms in rats.
    Noble LJ; Gonzalez IJ; Meruva VB; Callahan KA; Belfort BD; Ramanathan KR; Meyers E; Kilgard MP; Rennaker RL; McIntyre CK
    Transl Psychiatry; 2017 Aug; 7(8):e1217. PubMed ID: 28892066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single prolonged stress: toward an animal model of posttraumatic stress disorder.
    Yamamoto S; Morinobu S; Takei S; Fuchikami M; Matsuki A; Yamawaki S; Liberzon I
    Depress Anxiety; 2009; 26(12):1110-7. PubMed ID: 19918929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of neurosteroid biosynthesis as a pharmacological strategy to improve behavioural deficits in a putative mouse model of post-traumatic stress disorder.
    Pinna G; Rasmusson AM
    J Neuroendocrinol; 2012 Jan; 24(1):102-16. PubMed ID: 21981145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal Models of PTSD: The Socially Isolated Mouse and the Biomarker Role of Allopregnanolone.
    Pinna G
    Front Behav Neurosci; 2019; 13():114. PubMed ID: 31244621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress-induced enhancement of fear conditioning and sensitization facilitates extinction-resistant and habituation-resistant fear behaviors in a novel animal model of posttraumatic stress disorder.
    Corley MJ; Caruso MJ; Takahashi LK
    Physiol Behav; 2012 Jan; 105(2):408-16. PubMed ID: 21925525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].
    Auxéméry Y
    Encephale; 2012 Oct; 38(5):373-80. PubMed ID: 23062450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased 5-HT2C receptor editing predisposes to PTSD-like behaviors and alters BDNF and cytokines signaling.
    Règue M; Poilbout C; Martin V; Franc B; Lanfumey L; Mongeau R
    Transl Psychiatry; 2019 Feb; 9(1):100. PubMed ID: 30792491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid receptor activation is involved in producing abnormal phenotypes of single-prolonged stress rats: a putative post-traumatic stress disorder model.
    Kohda K; Harada K; Kato K; Hoshino A; Motohashi J; Yamaji T; Morinobu S; Matsuoka N; Kato N
    Neuroscience; 2007 Aug; 148(1):22-33. PubMed ID: 17644267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In a mouse model relevant for post-traumatic stress disorder, selective brain steroidogenic stimulants (SBSS) improve behavioral deficits by normalizing allopregnanolone biosynthesis.
    Pinna G
    Behav Pharmacol; 2010 Sep; 21(5-6):438-50. PubMed ID: 20716970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel rat model of comorbid PTSD and addiction reveals intersections between stress susceptibility and enhanced cocaine seeking with a role for mGlu5 receptors.
    Schwendt M; Shallcross J; Hadad NA; Namba MD; Hiller H; Wu L; Krause EG; Knackstedt LA
    Transl Psychiatry; 2018 Oct; 8(1):209. PubMed ID: 30291225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predator-based psychosocial stress animal model of PTSD: Preclinical assessment of traumatic stress at cognitive, hormonal, pharmacological, cardiovascular and epigenetic levels of analysis.
    Zoladz PR; Diamond DM
    Exp Neurol; 2016 Oct; 284(Pt B):211-219. PubMed ID: 27283115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycyrrhizin treatment ameliorates post-traumatic stress disorder-like behaviours and restores circadian oscillation of intracranial serotonin.
    Lai S; Shi L; Jiang Z; Lin Z
    Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):95-101. PubMed ID: 31494960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproic acid effects in the hippocampus and prefrontal cortex in an animal model of post-traumatic stress disorder.
    Wilson CB; McLaughlin LD; Ebenezer PJ; Nair AR; Francis J
    Behav Brain Res; 2014 Jul; 268():72-80. PubMed ID: 24675160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limbic Neuropeptidergic Modulators of Emotion and Their Therapeutic Potential for Anxiety and Post-Traumatic Stress Disorder.
    Marvar PJ; Andero R; Hurlemann R; Lago TR; Zelikowsky M; Dabrowska J
    J Neurosci; 2021 Feb; 41(5):901-910. PubMed ID: 33472824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From non-pharmacological treatments for post-traumatic stress disorder to novel therapeutic targets.
    Hendriksen H; Olivier B; Oosting RS
    Eur J Pharmacol; 2014 Jun; 732():139-58. PubMed ID: 24698651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated administration of AC-5216, a ligand for the 18 kDa translocator protein, improves behavioral deficits in a mouse model of post-traumatic stress disorder.
    Qiu ZK; Zhang LM; Zhao N; Chen HX; Zhang YZ; Liu YQ; Mi TY; Zhou WW; Li Y; Yang RF; Xu JP; Li YF
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():40-6. PubMed ID: 23624119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Status of Animal Models of Posttraumatic Stress Disorder: Behavioral and Biological Phenotypes, and Future Challenges in Improving Translation.
    Deslauriers J; Toth M; Der-Avakian A; Risbrough VB
    Biol Psychiatry; 2018 May; 83(10):895-907. PubMed ID: 29338843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.